| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | ISO | RGD:737223 | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of CXCL12 mRNA; more ... | CTD | PMID:22549810 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of CXCL12 protein]; more ... | CTD | PMID:22549810 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | affects response to substance | ISO | RGD:737223 | 6480464 | CXCL12 mRNA affects the susceptibility to 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | CTD | PMID:22549810 |
| 1,4-benzoquinone | increases expression | ISO | RGD:737223 | 6480464 | benzoquinone results in increased expression of CXCL12 mRNA | CTD | PMID:22960397 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:3651 | 6480464 | Ethinyl Estradiol results in decreased expression of CXCL12 mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | increases secretion | ISO | RGD:737223 | 6480464 | Ethinyl Estradiol results in increased secretion of CXCL12 protein | CTD | PMID:20549624 |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | affects response to substance | ISO | RGD:737223 | 6480464 | CXCL12 mRNA affects the susceptibility to Estradiol | CTD | PMID:22549810 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL12 protein] | CTD | PMID:22549810 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL12 mRNA] | CTD | PMID:17872378 PMID:22549810 |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:15913882 more ... |
| 17beta-estradiol | affects expression | ISO | RGD:737223 | 6480464 | Estradiol affects the expression of CXCL12 mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 protein | CTD | PMID:22549810 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737223 | 6480464 | Raloxifene inhibits the reaction [Estradiol results in increased expression of CXCL12 mRNA] | CTD | PMID:21185374 |
| 17beta-estradiol | increases secretion | ISO | RGD:737223 | 6480464 | Estradiol results in increased secretion of CXCL12 protein | CTD | PMID:20549624 |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:15913882 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:737223 | 6480464 | 4-hydroxytamoxifen inhibits the reaction [Estradiol results in increased secretion of CXCL12 protein]; more ... | CTD | PMID:20549624 |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:15913882 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:15913882 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:15986123 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:17555868 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:15986123 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:17555868 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:737223 | 6480464 | Estradiol results in increased expression of CXCL12 mRNA | CTD | PMID:17872378 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL12 mRNA] | CTD | PMID:17872378 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737223 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CXCL12 mRNA | CTD | PMID:19619570 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:737223 | 6480464 | Dihydrotestosterone results in decreased expression of CXCL12 mRNA; more ... | CTD | PMID:15953861 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | RGD:737223 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of CXCL12 mRNA | CTD | PMID:22262711 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737223 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CXCL12 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CXCL12 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3651 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:3651 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CXCL12 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:19770486 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737223 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:19619570 PMID:17517823 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:3651 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL12 mRNA | CTD | PMID:16960034 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL12 mRNA | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:18796159 PMID:16960034 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CXCL12 mRNA] | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA]; more ... | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of CXCL12 mRNA | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:737223 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CXCL12 mRNA | CTD | PMID:17555868 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737223 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 mRNA | CTD | PMID:17517823 PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737223 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CXCL12 protein | CTD | PMID:17517823 |
| 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of CXCL12 mRNA | CTD | PMID:15973123 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:3651 | 6480464 | 2,4-dinitrotoluene affects the expression of CXCL12 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:3651 | 6480464 | 2,6-dinitrotoluene affects the expression of CXCL12 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:3651 | 6480464 | [2-Acetylaminofluorene co-treated with Carbon Tetrachloride] results in increased expression of CXCL12 protein | CTD | PMID:12626097 |
| 2-acetamidofluorene | increases expression | ISO | RGD:3651 | 6480464 | 2-Acetylaminofluorene results in increased expression of CXCL12 protein; more ... | CTD | PMID:15579440 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:3651 | 6480464 | Glucosamine promotes the reaction [IL1B results in decreased expression of CXCL12 mRNA]; more ... | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:3651 | 6480464 | Glucosamine results in decreased expression of CXCL12 mRNA | CTD | PMID:17109745 |
| 26-hydroxycholesterol | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [27-hydroxycholesterol results in increased expression of CXCL12 mRNA] | CTD | PMID:17872378 |
| 26-hydroxycholesterol | increases expression | ISO | RGD:737223 | 6480464 | 27-hydroxycholesterol results in increased expression of CXCL12 mRNA | CTD | PMID:17872378 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA; more ... | CTD | PMID:16054899 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737223 | 6480464 | decitabine results in increased expression of CXCL12 mRNA | CTD | PMID:19289100 PMID:20562917 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737223 | 6480464 | decitabine results in increased expression of CXCL12 mRNA | CTD | PMID:20562917 PMID:19289100 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737223 | 6480464 | decitabine results in decreased methylation of CXCL12 promoter | CTD | PMID:20562917 |
| 5-azacytidine | decreases methylation | ISO | RGD:737223 | 6480464 | Azacitidine results in decreased methylation of CXCL12 promoter | CTD | PMID:19748759 |
| 5-azacytidine | increases expression | ISO | RGD:737223 | 6480464 | Azacitidine results in increased expression of CXCL12 mRNA; more ... | CTD | PMID:19748759 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of CXCL12 mRNA | CTD | PMID:16337237 |
| 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of CXCL12 mRNA | CTD | PMID:18344199 |
| 8'-apo-beta,psi-caroten-8'-al | increases expression | ISO | RGD:737223 | 6480464 | apocarotenal results in increased expression of CXCL12 mRNA | CTD | PMID:17034753 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CXCL12 mRNA | CTD | PMID:20711499 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:737223 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL12 mRNA | CTD | PMID:22079614 |
| afimoxifene | multiple interactions | ISO | RGD:737223 | 6480464 | 4-hydroxytamoxifen inhibits the reaction [Estrogens results in increased expression of CXCL12 mRNA] | CTD | PMID:21233418 |
| afimoxifene | multiple interactions | ISO | RGD:737223 | 6480464 | 4-hydroxytamoxifen inhibits the reaction [Estradiol results in increased secretion of CXCL12 protein] | CTD | PMID:20549624 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of CXCL12 mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:3651 | 6480464 | Glucosamine promotes the reaction [IL1B results in decreased expression of CXCL12 mRNA]; more ... | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:3651 | 6480464 | Glucosamine results in decreased expression of CXCL12 mRNA | CTD | PMID:17109745 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:737223 | 6480464 | [Tretinoin co-treated with CXCL12 protein] results in increased expression of PTK2B protein; more ... | CTD | PMID:17656649 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:3651 | 6480464 | Tretinoin results in decreased expression of CXCL12 mRNA | CTD | PMID:20488242 |
| all-trans-retinoic acid | increases expression | ISO | RGD:737223 | 6480464 | Tretinoin results in increased expression of CXCL12 mRNA; more ... | CTD | PMID:17656649 |
| ammonium chloride | affects expression | ISO | RGD:3651 | 6480464 | Ammonium Chloride affects the expression of CXCL12 mRNA | CTD | PMID:16483693 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CXCL12 mRNA | CTD | PMID:15120971 PMID:15122651 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of CXCL12 mRNA | CTD | PMID:15122651 PMID:15120971 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CXCL12 mRNA | CTD | PMID:19770486 PMID:21569818 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CXCL12 mRNA | CTD | PMID:22228805 PMID:22342234 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CXCL12 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CXCL12 mRNA | CTD | PMID:21569818 PMID:19770486 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CXCL12 mRNA | CTD | PMID:19770486 |
| beta-carotene | increases expression | ISO | RGD:737223 | 6480464 | beta Carotene results in increased expression of CXCL12 mRNA | CTD | PMID:17034753 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:3651 | 6480464 | Glucosamine promotes the reaction [IL1B results in decreased expression of CXCL12 mRNA]; more ... | CTD | PMID:17109745 |
| beta-D-glucosamine | decreases expression | ISO | RGD:3651 | 6480464 | Glucosamine results in decreased expression of CXCL12 mRNA | CTD | PMID:17109745 |
| bisphenol A | increases secretion | ISO | RGD:737223 | 6480464 | bisphenol A results in increased secretion of CXCL12 protein | CTD | PMID:20549624 |
| bisphenol A | affects response to substance | ISO | RGD:737223 | 6480464 | CXCL12 mRNA affects the susceptibility to bisphenol A | CTD | PMID:22549810 |
| bisphenol A | increases expression | ISO | RGD:737223 | 6480464 | bisphenol A results in increased expression of CXCL12 protein; more ... | CTD | PMID:22549810 |
| bisphenol A | multiple interactions | ISO | RGD:737223 | 6480464 | bisphenol A inhibits the reaction [Genistein results in increased expression of CXCL12 mRNA]; more ... | CTD | PMID:22549810 |
| bucladesine | decreases expression | EXP | | 6480464 | Bucladesine results in decreased expression of CXCL12 mRNA | CTD | PMID:20711499 |
| cadmium dichloride | increases expression | ISO | RGD:737223 | 6480464 | Cadmium Chloride results in increased expression of CXCL12 mRNA | CTD | PMID:12160620 |
| calcium atom | increases uptake | ISO | RGD:737223 | 6480464 | CXCL12 protein results in increased uptake of Calcium | CTD | PMID:11872090 PMID:10984371 |
| calcium atom | increases uptake | ISO | RGD:737223 | 6480464 | CXCL12 protein results in increased uptake of Calcium | CTD | PMID:10984371 PMID:11872090 |
| calcium atom | multiple interactions | ISO | RGD:737223 | 6480464 | resveratrol inhibits the reaction [CXCL12 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| calcium(0) | increases uptake | ISO | RGD:737223 | 6480464 | CXCL12 protein results in increased uptake of Calcium | CTD | PMID:11872090 PMID:10984371 |
| calcium(0) | increases uptake | ISO | RGD:737223 | 6480464 | CXCL12 protein results in increased uptake of Calcium | CTD | PMID:10984371 PMID:11872090 |
| calcium(0) | multiple interactions | ISO | RGD:737223 | 6480464 | resveratrol inhibits the reaction [CXCL12 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| cetrorelix | decreases expression | ISO | RGD:737223 | 6480464 | cetrorelix results in decreased expression of CXCL12 mRNA | CTD | PMID:21062912 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of CXCL12 mRNA | CTD | PMID:18353800 |
| ciprofibrate | decreases expression | EXP | | 6480464 | ciprofibrate results in decreased expression of CXCL12 mRNA | CTD | PMID:12771043 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CXCL12 mRNA | CTD | PMID:21151649 |
| clofibric acid | decreases expression | ISO | RGD:737223 | 6480464 | Clofibric Acid results in decreased expression of CXCL12 mRNA | CTD | PMID:21214675 |
| clofibric acid | affects expression | ISO | RGD:3651 | 6480464 | Clofibric Acid affects the expression of CXCL12 mRNA | CTD | PMID:17602206 |
| clofibric acid | multiple interactions | ISO | RGD:3651 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CXCL12 mRNA | CTD | PMID:17602206 |
| coumarin | decreases expression | ISO | RGD:3651 | 6480464 | coumarin results in decreased expression of CXCL12 mRNA | CTD | PMID:18480146 |
| coumestrol | multiple interactions | ISO | RGD:737223 | 6480464 | [Coumestrol co-treated with ESR1 protein] results in increased expression of CXCL12 mRNA; more ... | CTD | PMID:18310284 |
| coumestrol | increases expression | ISO | RGD:737223 | 6480464 | Coumestrol results in increased expression of CXCL12 mRNA | CTD | PMID:19167446 |
| coumestrol | multiple interactions | ISO | RGD:737223 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CXCL12 mRNA | CTD | PMID:19167446 |
| curcumin | multiple interactions | ISO | RGD:737223 | 6480464 | Curcumin inhibits the reaction [CXCL12 protein results in increased expression of CXCR4 mRNA]; more ... | CTD | PMID:18660423 |
| cyclophosphamide | affects expression | EXP | | 6480464 | Cyclophosphamide affects the expression of CXCL12 mRNA | CTD | PMID:12624490 |
| cyclophosphamide | increases expression | ISO | RGD:3651 | 6480464 | Cyclophosphamide results in increased expression of CXCL12 protein | CTD | PMID:19066630 PMID:20032115 |
| cyclophosphamide | increases expression | ISO | RGD:3651 | 6480464 | Cyclophosphamide results in increased expression of CXCL12 protein | CTD | PMID:20032115 PMID:19066630 |
| cyclophosphamide | increases expression | ISO | RGD:3651 | 6480464 | Cyclophosphamide results in increased expression of CXCL12 mRNA | CTD | PMID:20032115 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of CXCL12 mRNA | CTD | PMID:16337237 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CXCL12 mRNA | CTD | PMID:19770486 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:737223 | 6480464 | dasatinib results in decreased expression of CXCL12 protein | CTD | PMID:17962511 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA; more ... | CTD | PMID:16054899 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CXCL12 mRNA | CTD | PMID:21041162 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CXCL12 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:3651 | 6480464 | Dibutyl Phthalate results in decreased expression of CXCL12 mRNA | CTD | PMID:21266533 |
| diethyl maleate | decreases expression | ISO | RGD:3651 | 6480464 | diethyl maleate results in decreased expression of CXCL12 mRNA | CTD | PMID:21161181 |
| dioxygen | multiple interactions | EXP | | 6480464 | HMOX1 protein promotes the reaction [Oxygen deficiency results in increased expression of CXCL12 mRNA]; more ... | CTD | PMID:21048024 |
| dioxygen | increases response to substance | ISO | RGD:737223 | 6480464 | Oxygen deficiency results in increased susceptibility to CXCL12 protein | CTD | PMID:17476338 |
| dioxygen | multiple interactions | ISO | RGD:3651 | 6480464 | Oxygen deficiency results in increased expression of and results in increased secretion of CXCL12 protein; more ... | CTD | PMID:18803305 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of CXCL12 mRNA; more ... | CTD | PMID:21048024 |
| dipyridamole | decreases expression | EXP | | 6480464 | Dipyridamole results in decreased expression of CXCL12 mRNA | CTD | PMID:20711499 |
| disodium selenite | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of CXCL12 mRNA] | CTD | PMID:17997286 |
| diuron | decreases expression | ISO | RGD:3651 | 6480464 | Diuron results in decreased expression of CXCL12 mRNA | CTD | PMID:21551480 |
| edaravone | multiple interactions | ISO | RGD:3651 | 6480464 | phenylmethylpyrazolone inhibits the reaction [SDC2 protein results in increased expression of and results in increased secretion of CXCL12 protein]; more ... | CTD | PMID:18803305 |
| etoposide | decreases expression | ISO | RGD:737223 | 6480464 | Etoposide results in decreased expression of CXCL12 mRNA; more ... | CTD | PMID:22363485 |
| fulvestrant | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL12 mRNA]; more ... | CTD | PMID:17872378 |
| fulvestrant | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL12 protein]; more ... | CTD | PMID:22549810 |
| fulvestrant | multiple interactions | ISO | RGD:737223 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL12 mRNA] | CTD | PMID:17872378 PMID:22549810 |
| fumonisin B1 | decreases expression | EXP | | 6480464 | fumonisin B1 results in decreased expression of CXCL12 mRNA | CTD | PMID:16221962 |
| gadodiamide hydrate | increases expression | ISO | RGD:737223 | 6480464 | gadodiamide results in increased expression of CXCL12 mRNA | CTD | PMID:20959327 |
| genistein | increases secretion | ISO | RGD:737223 | 6480464 | Genistein results in increased secretion of CXCL12 protein | CTD | PMID:20549624 |
| genistein | increases expression | ISO | RGD:737223 | 6480464 | Genistein results in increased expression of CXCL12 mRNA; more ... | CTD | PMID:22549810 |
| genistein | affects response to substance | ISO | RGD:737223 | 6480464 | CXCL12 mRNA affects the susceptibility to Genistein | CTD | PMID:22549810 |
| genistein | multiple interactions | ISO | RGD:737223 | 6480464 | bisphenol A inhibits the reaction [Genistein results in increased expression of CXCL12 mRNA]; more ... | CTD | PMID:22549810 |
| heparin | decreases expression | ISO | RGD:737223 | 6480464 | Heparin analog results in decreased expression of CXCL12 mRNA; more ... | CTD | PMID:20201787 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of CXCL12 mRNA | CTD | PMID:17997286 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [Hydrogen Peroxide results in increased expression of CXCL12 mRNA] | CTD | PMID:17997286 |
| hydroquinone | decreases expression | ISO | RGD:737223 | 6480464 | hydroquinone results in decreased expression of CXCL12 mRNA | CTD | PMID:22960397 |
| isotretinoin | increases expression | ISO | RGD:737223 | 6480464 | Isotretinoin results in increased expression of CXCL12 mRNA | CTD | PMID:20436886 |
| melphalan | decreases expression | ISO | RGD:737223 | 6480464 | Melphalan results in decreased expression of CXCL12 mRNA; more ... | CTD | PMID:22363485 |
| methotrexate | increases expression | ISO | RGD:737223 | 6480464 | Methotrexate results in increased expression of CXCL12 mRNA | CTD | PMID:17400583 |
| methylmercury chloride | affects expression | ISO | RGD:3651 | 6480464 | methylmercuric chloride affects the expression of CXCL12 mRNA | CTD | PMID:20864626 |
| mifepristone | increases expression | ISO | RGD:737223 | 6480464 | Mifepristone results in increased expression of CXCL12 mRNA | CTD | PMID:17584828 |
| mycophenolic acid | increases expression | EXP | | 6480464 | Mycophenolic Acid results in increased expression of CXCL12 mRNA | CTD | PMID:19818335 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CXCL12 mRNA | CTD | PMID:19840844 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:3651 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CXCL12 mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:3651 | 6480464 | Diethylnitrosamine results in decreased expression of CXCL12 mRNA | CTD | PMID:19041683 PMID:19638242 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:3651 | 6480464 | Diethylnitrosamine results in decreased expression of CXCL12 mRNA | CTD | PMID:19638242 PMID:19041683 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:3651 | 6480464 | Diethylnitrosamine results in decreased expression of CXCL12 mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CXCL12 mRNA | CTD | PMID:12771043 |
| nickel dichloride | decreases secretion | ISO | RGD:737223 | 6480464 | nickel chloride results in decreased secretion of CXCL12 protein | CTD | PMID:18437699 |
| nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide deficiency results in decreased expression of CXCL12 mRNA | CTD | PMID:15878706 |
| okadaic acid | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of CXCL12 mRNA | CTD | PMID:19840844 |
| oxaliplatin | decreases expression | ISO | RGD:737223 | 6480464 | oxaliplatin results in decreased expression of CXCL12 mRNA | CTD | PMID:17762391 |
| paracetamol | decreases expression | ISO | RGD:3651 | 6480464 | Acetaminophen results in decreased expression of CXCL12 mRNA | CTD | PMID:17202762 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CXCL12 mRNA | CTD | PMID:17562736 |
| permethrin | increases expression | ISO | RGD:3651 | 6480464 | Permethrin results in increased expression of CXCL12 mRNA | CTD | PMID:19017407 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CXCL12 mRNA] | CTD | PMID:19482888 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CXCL12 mRNA | CTD | PMID:19482888 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:737223 | 6480464 | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CXCL12 mRNA]] | CTD | PMID:22643241 |
| pioglitazone | decreases response to substance | ISO | RGD:737223 | 6480464 | pioglitazone results in decreased susceptibility to CXCL12 protein | CTD | PMID:18158351 |
| pioglitazone | multiple interactions | ISO | RGD:737223 | 6480464 | pioglitazone inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein] | CTD | PMID:18158351 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CXCL12 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CXCL12 mRNA | CTD | PMID:16221962 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CXCL12 mRNA | CTD | PMID:18445702 more ... |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of CXCL12 mRNA | CTD | PMID:17950772 more ... |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CXCL12 mRNA] | CTD | PMID:17950772 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of CXCL12 mRNA | CTD | PMID:19363144 |
| raloxifene | multiple interactions | ISO | RGD:737223 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of CXCL12 mRNA | CTD | PMID:19059307 |
| raloxifene | multiple interactions | ISO | RGD:737223 | 6480464 | Raloxifene inhibits the reaction [Estradiol results in increased secretion of CXCL12 protein] | CTD | PMID:20549624 |
| raloxifene | multiple interactions | ISO | RGD:737223 | 6480464 | Raloxifene inhibits the reaction [Estradiol results in increased expression of CXCL12 mRNA] | CTD | PMID:21185374 |
| resveratrol | multiple interactions | ISO | RGD:737223 | 6480464 | resveratrol inhibits the reaction [CXCL12 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| resveratrol | multiple interactions | ISO | RGD:737223 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CXCL12 mRNA | CTD | PMID:19167446 |
| rosiglitazone | decreases response to substance | ISO | RGD:737223 | 6480464 | rosiglitazone results in decreased susceptibility to CXCL12 protein | CTD | PMID:18158351 |
| rosiglitazone | affects expression | ISO | RGD:3651 | 6480464 | rosiglitazone affects the expression of CXCL12 mRNA | CTD | PMID:21515302 |
| rosiglitazone | decreases expression | ISO | RGD:3651 | 6480464 | rosiglitazone results in decreased expression of CXCL12 mRNA | CTD | PMID:17713437 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CXCL12 mRNA; more ... | CTD | PMID:16054899 |
| rosiglitazone | multiple interactions | ISO | RGD:737223 | 6480464 | rosiglitazone inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein] | CTD | PMID:18158351 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases expression | EXP | | 6480464 | Buthionine Sulfoximine results in decreased expression of CXCL12 mRNA | CTD | PMID:15878706 |
| simvastatin | increases expression | ISO | RGD:3651 | 6480464 | Simvastatin results in increased expression of CXCL12 | CTD | PMID:19591934 |
| sodium dichromate | increases expression | ISO | RGD:3651 | 6480464 | sodium bichromate results in increased expression of CXCL12 mRNA | CTD | PMID:22561333 |
| sterigmatocystin | increases expression | EXP | | 6480464 | Sterigmatocystin results in increased expression of CXCL12 mRNA | CTD | PMID:19818335 |
| tamoxifen | multiple interactions | ISO | RGD:737223 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of CXCL12 mRNA | CTD | PMID:19059307 |
| tamoxifen | decreases methylation | ISO | RGD:737223 | 6480464 | Tamoxifen results in decreased methylation of CXCL12 promoter | CTD | PMID:19748759 |
| tamoxifen | increases expression | ISO | RGD:737223 | 6480464 | Tamoxifen results in increased expression of CXCL12 protein; more ... | CTD | PMID:19748759 |
| telmisartan | multiple interactions | ISO | RGD:737223 | 6480464 | PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]] | CTD | PMID:18158351 |
| telmisartan | decreases response to substance | ISO | RGD:737223 | 6480464 | telmisartan results in decreased susceptibility to CXCL12 protein | CTD | PMID:18158351 |
| tetrachloromethane | multiple interactions | ISO | RGD:3651 | 6480464 | [2-Acetylaminofluorene co-treated with Carbon Tetrachloride] results in increased expression of CXCL12 protein | CTD | PMID:12626097 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CXCL12 mRNA | CTD | PMID:17484886 |
| tetraphene | increases expression | ISO | RGD:737223 | 6480464 | benz(a)anthracene results in increased expression of CXCL12 mRNA | CTD | PMID:22643241 |
| tetraphene | multiple interactions | ISO | RGD:737223 | 6480464 | Tetradecanoylphorbol Acetate inhibits the reaction [benz(a)anthracene results in increased expression of CXCL12 mRNA]; more ... | CTD | PMID:22643241 |
| titanium dioxide | increases expression | ISO | RGD:737223 | 6480464 | titanium dioxide results in increased expression of CXCL12 mRNA | CTD | PMID:19695317 |
| trans-resveratrol | multiple interactions | ISO | RGD:737223 | 6480464 | resveratrol inhibits the reaction [CXCL12 protein affects the localization of Calcium] | CTD | PMID:16212921 |
| trans-resveratrol | multiple interactions | ISO | RGD:737223 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CXCL12 mRNA | CTD | PMID:19167446 |
| trichostatin A | increases expression | ISO | RGD:737223 | 6480464 | trichostatin A results in increased expression of CXCL12 mRNA | CTD | PMID:19289100 |
| trimellitic anhydride | decreases expression | EXP | | 6480464 | trimellitic anhydride results in decreased expression of CXCL12 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:3651 | 6480464 | troglitazone results in decreased expression of CXCL12 mRNA | CTD | PMID:21515302 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CXCL12 mRNA | CTD | PMID:21427059 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of CXCL12 mRNA | CTD | PMID:22045034 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CXCL12 mRNA | CTD | PMID:21427059 PMID:19136453 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CXCL12 mRNA | CTD | PMID:19136453 PMID:21427059 |
| vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of CXCL12 mRNA | CTD | PMID:18930951 |
| zalcitabine | increases expression | ISO | RGD:3651 | 6480464 | Zalcitabine results in increased expression of CXCL12 mRNA | CTD | PMID:17292584 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CXCL12 mRNA | CTD | PMID:20857495 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of CXCL12 mRNA | CTD | PMID:20857495 |